Stockscreener 앱 받기
6.93
4.55%
-0.33
시간 외 거래:
6.91
-0.02
-0.29%
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in - The National Law Review
Quantum BioPharma closes private placement, enhances governance - MSN
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in a Securities Fraud LawsuitContact Kaplan Fox & Kilsheimer LLP - NewMediaWire
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - The Ithaca Journal
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge - MSN
Deadline to Lead in Securities Class Action Against Quantum Biopharma Ltd. (QNTM) is February 23, 2026Contact Kaplan Fox - FinancialContent
How supply chain issues affect Quantum BioPharma Ltd. stockJuly 2025 Big Picture & AI Forecasted Stock Moves - ulpravda.ru
Will Quantum BioPharma Ltd. stock attract ESG investorsJuly 2025 Momentum & Stepwise Trade Signal Guides - ulpravda.ru
How strong is Quantum BioPharma Ltd. stock balance sheetTreasury Yields & Real-Time Volume Trigger Notifications - ulpravda.ru
Will Quantum BioPharma Ltd. (0K91) stock enhance shareholder value2025 Price Momentum & Free Expert Verified Stock Movement Alerts - ulpravda.ru
QNTM CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Why Quantum BioPharma Ltd. (0K91) stock signals breakout potentialTreasury Yields & Consistent Growth Stock Picks - ulpravda.ru
How Quantum BioPharma Ltd. stock reacts to global recession fearsRetail Trading Trends & Budget Friendly Trading Ideas - ulpravda.ru
Is Quantum BioPharma Ltd. (0K91) stock dividend growth reliableStock Watchlist Updates & Big Returns Small Capital - ulpravda.ru
QNTM DEADLINE: Investors of Quantum Biopharma Ltd. (QNTM) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Se - The National Law Review
Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Securities Class Action LawsuitDeadline is February 23, 2026 - FinancialContent
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QUANTUM BIOPHARMA Investors are Encouraged to Contact Kaplan Fox Regarding the Securities Class Action Lawsuit - NewMediaWire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
Kaplan Fox Reminds Quantum Biopharma Ltd. (QNTM) Investors of a Securities Class Action Lawsuit - The Globe and Mail
Kaplan Fox Encourages Investors of Quantum Biopharma Ltd. (QNTM) to Contact the Firm Regarding the Securities Class Action Lawsuit - NewMediaWire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox Alerts Investors of Quantum Biopharma Ltd. (QNTM) to a Securities Class Action Lawsuit - The National Law Review
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Contact UsConcord Monitor - FinancialContent
Kaplan Fox Alerts Investors to Securities Class Action on Behalf of Quantum Biopharma Ltd. (QNTM) Shareholders - NewMediaWire
Cannabis Stocks To Follow TodayDecember 11th - MarketBeat
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Celly Nutrition targets IPO with $10 million capital raise - MSN
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum BioPharma Ltd Stock Analysis and ForecastVolatility Adjusted Trading & Small Budget Capital Gains - earlytimes.in
Quantum BioPharma completes key toxicity studies for Lucid-MS, paving way for Phase 2 MS trial - Indian Pharma Post
Cannabis Stocks To Follow NowDecember 1st - MarketBeat
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - The Malaysian Reserve
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum BioPharma completes oral dosing in key MS drug studies By Investing.com - Investing.com Australia
Quantum BioPharma completes 180-day toxicity dosing for lead MS drug Lucid-MS - MSN
0.90%
자본화:
|
볼륨(24시간):